Buys
Open market- Shares
- Avg price
- Total value
Elizabeth H.z. Thompson - EVP, Head of Research & Dev at ACADIA PHARMACEUTICALS INC
Issuer-level insider activity
- Role
- EVP, Head of Research & Dev
- Issuer ticker
- ACAD on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Elizabeth H.z. Thompson in ACADIA PHARMACEUTICALS INC
Sells
Open market- Shares
- -19,993
- Avg price
- $25.33
- Total value
- -$506,412
Net
Past year- Shares
- -19,993
- Share %
- -100%
- Total value
- -$506,412
Reported holdings for Elizabeth H.z. Thompson in ACADIA PHARMACEUTICALS INC
Form 4 holding
EVP, Head of Research & Dev
ACADIA PHARMACEUTICALS INC
- Security class
- Common Stock
- Shares / value
- 18,994
- Estimated value
- $497,072
- Report date
- 30 Jul 2026
- Price
- $26.17
- Ownership
- Direct
Form 4 holding
EVP, Head of Research & Dev
ACADIA PHARMACEUTICALS INC
- Security class
- Restricted Stock Units
- Shares / value
- 32,272
- Estimated value
- $489,676
- Report date
- 29 Jul 2026
- Price
- $18.23
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
EVP, Head of Research & Dev
ACADIA PHARMACEUTICALS INC
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 101,574
- Estimated value
- Report date
- 06 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Elizabeth H.z. Thompson in ACADIA PHARMACEUTICALS INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.